Tag Archive for: Forendo

Novo Seeds Provides Business Update on a Record Year – Building Exceptional Companies for Global Impact

/in

Over US$ 550 million raised by portfolio companies in 2021 IO Biotech IPO on US NASDAQ Forendo Pharma acquired for nearly US$ 1 billion Muna launched with world-leading science to advance latest scientific breakthroughs in neuroscience Adcendo raised US$ 60 million Series A to deliver next-generation Antibody-Drug Conjugates Hemab raised US$ 50 million Series A to […]

Read more

Forendo Pharma signs important License and Collaboration Deal with Leading Pharma Company

/in

Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women’s health, today announces signing of a License and Collaboration Agreement with Novartis. The joint research collaboration is aimed at the identification of novel drugs for the treatment of chronic liver diseases. Novartis receives a worldwide exclusive license to drug candidates generated […]

Read more